Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry-Reference-Cited by-同舟云学术

Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry

Published:2018-12-04 Issue:6 Volume:184 Page:949-956
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hohloch Karin¹²^ORCID,Windemuth-Kieselbach Christiane³,Kolz Julia²,Zinzani Pier Luigi⁴^ORCID,Cacchione Roberto⁵,Jurczak Woijciech⁶,Bischof Delaloye Angelika⁷,Trümper Lorenz⁴,Scholz Christian W.⁸

Affiliation:

1. Kantonsspital Graubünden; Department of Haematology and Oncology; Chur Switzerland

2. Department of Haematology and Oncology; Georg August University; Goettingen Germany

3. Alcedis GmbH; Independent CRO; Giessen Germany

4. Istituto di Ematologia e Oncologia Medica; Università di Bologna; Bologna Italy

5. CEMIC; Centro de Educación, Médica e Investigaciones Clínical; “Norberto Quirno”; Buenos Aires Argentina

6. Department of Haematology; Jagiellonian University; Cracow Poland

7. Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland

8. Department of Haematology and Oncology; Vivantes Klinikum Am Urban; Berlin Germany

Funder

Spectrum Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15712/fullpdf

Reference29 articles.

1. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma;Al-Tourah;Journal of Clinical Oncology,2008

2. 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years;Casadei;Cancer Medicine,2016

3. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project;Federico;Journal of Clinical Oncology,2009

4. Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study;Fowler;Journal of Clinical Oncology,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rare case of follicular lymphoma of the bladder;Urology Case Reports;2023-11

2. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma;Future Oncology;2023-10

3. Radioimmunotherapy with ¹³¹I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma;Asia-Pacific Journal of Clinical Oncology;2023-03-13

4. Radionuclide Therapy of Lymphomas;Nuclear Oncology;2022

5. Radionuclide Therapy of Lymphomas;Nuclear Oncology;2022